Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was originally approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2D). Current ...

Bryce Huff’s roller coaster season with the Eagles — his first away from the Jets after inking a three-year, $51 million deal in free agency — came to a crashing halt Sunday, as the edge ...

You can find him at X @james_brizuela. The Philadelphia Eagles have released their official inactive list. The team got some good news per one important injury, Brandon Graham is officially active.

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Ozempic (semaglutide) is a subcutaneous injection used in people with type 2 diabetes. It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic ...

We even discuss the role of dietary fructose and how it impacts metabolic health, particularly for inactive individuals ... role of medications like semaglutide in weight management.

Hims & Hers’ Super Bowl ad plugs its compounded weight loss drugs as the “affordable” solution to a “sick system,” but many concerns about safety still swirl around these forms of the ...